Note

pubs.acs.org/joc

Ru-Catalyzed Asymmetric Transfer Hydrogenation of
α‑Triﬂuoromethylimines
Meng Wu, Tanyu Cheng, Min Ji, and Guohua Liu*
Key Laboratory of Resource Chemistry of Ministry of Education, Shanghai Key Laboratory of Rare Earth Functional Materials,
Shanghai Normal University, Shanghai 200234, P. R. China
*S Supporting Information

ABSTRACT: Enantioselective transformation of strong electron-withdrawing
acyclic α-triﬂuoromethylimines to α-triﬂuoromethylamines through a ruthenium-
catalyzed asymmetric transfer hydrogenation has been developed. The method
described here is a facile catalytic process with sodium formate as a hydrogen
resource and water−dimethylformamide as a cosolvent. The beneﬁt of this
enantioselective transformation aﬀords a series of chiral α-triﬂuoromethylamines
with high yields and excellent enantioselectivities (93−99% ee) under mild
reaction conditions.

S ince the pioneering works reported by Noyori, Ikariya, and

co-workers on ruthenium(II)(diphosphine)(diamine) di-
chloride complexes for asymmetric hydrogenation of ketones
and imines,1 a large number of reviews and researches involving
in N-sulfonylated 1,2-diamines as chiral
ligands both in
asymmetric hydrogenation and in asymmetric transfer hydro-
genation of ketones and imines are well-documented
theoretically and practically.2 Also, various catalytic reaction
systems covering 2-propanol, formic acid−triethylamine, formic
acid, and sodium formate as hydrogen resources have been
explored in asymmetric transfer hydrogenation of ketones and
imines.3 Most prominent examples employ chiral N-sulfony-
lated diamine-based η5-Cp*−M complexes (η5-Cp* = pentam-
ethyl cyclopentadiene series) and η6-arene−M complexes (η6-
arene = aromatic ring series) (M = Ru, Rh, and Ir), which have
been applied extensively to various asymmetric transfer
hydrogenation of ketones and imine.4 Although these fruitful
achievements have been obtained,
in
triﬂuoromethylimines re-
enantioselective transformation of
main an unmet challenge.

their applications

Optically pure α-triﬂuoromethylamine, as an important
number of biologically active motifs, has been attracting
much interest in medical and ﬂuorine chemistry.5 Recently,
besides the methods of diastereoselective reductive aminations
and asymmetric addition,6 the construction of chiral α-
triﬂuoromethylamines through enantioselective reduction of
achiral α-triﬂuoromethylimines had been explored by a few
groups.7 The ﬁrst
two successful examples utilized an
asymmetric hydrogenation method reported by the Uneyama
and Zhou groups,7b−d in which Pd-catalyzed asymmetric
reactions could aﬀord chiral α-triﬂuoromethylamines with up
to 94% enantioselectivity. However, high pressures of hydrogen
and sensitive chiral diphosphine ligands still
limited their
practical applications. Interestingly, the latter three examples
employed asymmetric transfer hydrogenation and asymmetric
hydrosilylation methods to prepare chiral α-triﬂuoromethyla-
mines.7e−g As shown in Scheme 1, the Akiyama group7e used an

Scheme 1. Asymmetric Transfer Hydrogenation (ATH) and
Asymmetric Hydrosilylation (AHS) of 4-Methoxy-N-(2,2,2-
triﬂuoro-1-phenylethylidene)aniline

asymmetric transfer hydrogenation method through the use of
a chiral phosphoric acid as a catalyst and benzothiazoline as a
hydrogen resource to provide chiral 4-methoxy-N-(2,2,2-
triﬂuoro-1-phenylethyl)aniline with 96% ee, while the Benaglia
group7f utilized an asymmetric hydrosilylation method through
the use of a chiral organocatalyst (picolinamide) as a catalyst to

Received:
January 30, 2015
Published: March 11, 2015

© 2015 American Chemical Society

3708

DOI: 10.1021/acs.joc.5b00177
J. Org. Chem. 2015, 80, 3708−3713

The Journal of Organic Chemistry

obtain 91% ee of chiral 4-methoxy-N-(2,2,2-triﬂuoro-1-
phenylethyl)aniline. In particular, the Cahard group7g took
advantage of the η6-arene−Ru complex (chiral aminoalcohol/
[RuCl2(p-cymene)]2) as a catalyst and 2-propanol as a
hydrogen resource to enable enantioselective reduction of
achiral 4-methoxy-N-(2,2,2-triﬂuoro-1-phenylethylidene)aniline
to chiral 4-methoxy-N-(2,2,2-triﬂuoro-1-phenylethyl)aniline
(93% ee) through an asymmetric transfer hydrogenation
method. Although the above three examples had been
presented successfully, the ﬁrst two examples needed 10 mol
% of catalyst to reach their enantioselective performances, while
ee values in Ru-catalyzed asymmetric transfer hydrogenation
with 5 mol % of catalyst in the last example needed to be
further enhanced. Therefore, by utilizing chiral N-sulfonylated
diamine-based catalysts, realization of highly eﬃcient asym-
metric transfer hydrogenation of α-triﬂuoromethylimines with a
low catalyst’s amount under mild reaction conditions is high
desirable.

As an eﬀort

to develop highly eﬃcient catalysts

for
asymmetric transfer hydrogenation,8 we herein screen a series
of N-(4-methyl)benzenesulfonylated 1,2-diphenylethylene-
diamine (TsDPEN)-based η6-arene−M complexes to identify
a TsDPEN-based η6-mesitylene−Ru complex as an optimal
catalyst, realizing an eﬃciently ruthenium-catalyzed asymmetric
transfer hydrogenation of achiral aryltriﬂuoromethylimines to
chiral aryltriﬂuoromethylamines with 2 mol % of catalyst under
mild reaction conditions.
<para sub=“opt”>
On the basis of the idea in further development of chiral N-
sulfonylated diamine-based η6-arene−M complexes for asym-
metric transfer hydrogenation of triﬂuoromethylimines, the η6-
arene−Ru complex was investigated in asymmetric transfer
hydrogenation of 4-methoxy-N-(2,2,2-triﬂuoro-1-phenyl-
ethylidene)aniline under diﬀerent reaction conditions, respec-
tively. According to four common hydrogen resources, formic
acid−triethylamine,
formic acid, 2-propanol, and sodium
formate, we screened its catalytic performance at ﬁrst. As
shown in Table 1, it was found that, in the case of HCOOH−
NEt3 cosolvent as a hydrogen resource, poor yield and medium
enantioselectivity were obtained because the decomposition of
</para>
Table 1. Optimization of H Resource and Catalysts for
Asymmetric Transfer Hydrogenationa

entry

1
2
3
4
5
6
7

cat.
A
A
A
A
B
C
D

solvent and/or H resource

time (h)

yield (%)

ee (%)b

HCOOH−NEt3
HCOOH
i-PrOH
H2O−HCOONa
H2O−HCOONa
H2O−HCOONa
H2O−HCOONa

24
24
24
24
24
24
24

49
43
38
86
83
50
10

78
68
86
89
86
70
57

aReactions were performed with 4.0 μmol of catalyst, 0.20 mmol of 4-
methoxy-N-(2,2,2-triﬂuoro-1-phenylethylidene)aniline in 2.0 mL of
solvent at 40 °C. bDetermined by HPLC.

Note
<para sub=“opt”>
4-methoxy-N-(2,2,2-triﬂuoro-1-phenylethylidene)aniline pro-
duced the side product of 2,2,2-triﬂuoro-1-phenylethanol
(Table 1, entry 1).7g Similarly, the decomposition also existed
in the case of HCOOH as a hydrogen resource (Table 1, entry
2). Diﬀering from the above hydrogen resources,
the
asymmetric reaction with i-PrOH as a hydrogen resource had
a high enantioselectivity (86% ee), but the yield was poor
(Table 1, entry 3). To our delight, in the case of HCOONa as a
hydrogen resource and water as a solvent that was inspired by
the works of the Xiao and Deng groups on asymmetric transfer
hydrogenation of quinolines and N-sulfonylimines,9 we found
that catalyst A could produce the desirable (S)-4-methoxy-N-
(2,2,2-triﬂuoro-1-phenylethyl)aniline with 86% yield and 89%
ee (Table 1, entry 4).
</para>
<para sub=“opt”>
On the basis of this ﬁnding, we further investigated the
diﬀerent η6-arene−Ru complexes in the asymmetric transfer
hydrogenation of 4-methoxy-N-(2,2,2-triﬂuoro-1-phenyl-
ethylidene)aniline using HCOONa as a hydrogen resource
and water as a solvent. As shown in entries 5−7 of Table 1, it
was found that catalyst A aﬀorded the desirable products
slightly higher than that of catalyst B (Table 1, entries 4−5),
and markedly better than those of catalysts C and D (Table 1,
entry 4 versus entries 6−7). Therefore, (S,S)-TsPDEN/
[RuCl2(mesitylene)]2 (A) was identiﬁed as an optimal catalyst
through the use of HCOONa as a hydrogen resource and water
as a solvent.
</para>
<para sub=“opt”>
solubility of

Due to poor

substrates, optimization of
cosolvent using A as a catalyst was further attempted. As
shown Table 2, it was found that the enantioselectivity of the
</para>
Table 2. Optimization of Cosolvent for Asymmetric Transfer
Hydrogenationa

entry

1
2
3
4
5
6

cat.
A
A
A
A
A
A

cosolvent

time (h)

yield (%)

ee (%)b

H2O/THF (1:1)
H2O/dioxane (1:1)
H2O/i-PrOH (1:1)
H2O/DMA (1:1)
H2O/DMSO (1:1)
H2O/DMF (1:1)

24
24
24
8
8
8

70
88
40
91
92
93

54
nd
96
93
96
97

aReactions were performed with 4.0 μmol of catalyst, 0.20 mmol of 4-
methoxy-N-(2,2,2-triﬂuoro-1-phenylethylidene)aniline, 1.0 mmol of
HCOONa in 2.0 mL of cosolvent at 40 °C. bDetermined by HPLC.
<para sub=“opt”>
asymmetric reaction with H2O/DMF (v/v = 1:1) as a cosolvent
could further enhance from 89% to 97% ee, where the reaction
time could be decreased to 8 h because of the good-solubility of
the substrate in the mixed H2O/DMF cosolvent system (Table
2, entry 6). As compared with the other cosolvents, such an ee
value was obviously higher than those obtained with the mixed
H2O/THF and H2O/dioxane as cosolvents (Table 2, entry 6
versus entries 1−2), and slightly higher than those obtained
with the others (Table 2, entry 6 versus entries 3−5).
Therefore, the mixed H2O/DMF (v/v = 1:1) was identiﬁed
as an optimal cosolvent. As a comprehensive result,
the
</para>
3709

DOI: 10.1021/acs.joc.5b00177
J. Org. Chem. 2015, 80, 3708−3713

The Journal of Organic Chemistry
<para sub=“opt”>
asymmetric reaction with 2.0 mmol % of A as a catalyst,
HCOONa as a hydrogen resource, and H2O/DMF (v/v = 1:1)
as a cosolvent at 40 °C was determined as the optimal reaction
condition.
</para>
<para sub="scope">
Having established that catalyst A enabled a highly eﬃcient
asymmetric transfer hydrogenation of 4-methoxy-N-(2,2,2-
triﬂuoro-1-phenylethylidene)aniline, we further investigated its
general applicability to prepare chiral aryltriﬂuoromethylamines
with a series of aryl-substituted substrates. As shown in Table 3,
</para>
Table 3. Substrate Scope for Ru-Catalyzed Asymmetric
Transfer Hydrogenation of α-Triﬂuoromethyliminesa

Note
<para sub="scope">
As mentioned in the part of the Introduction, chiral 2,2,2-
triﬂuoro-1-phenylethanamine as an important synthetic motif
could be converted to various optically pure biologically active
molecules in medical and ﬂuorine chemistry.5 In this case, in
order to obtain optically pure 2,2,2-triﬂuoro-1-phenylethan-
amine, we attempted to remove the PMP protection group of
the hydrogenated product (S)-4-methoxy-N-(2,2,2-triﬂuoro-1-
phenylethyl)aniline. Among those reported methods,6c,7d,g,10 it
was found that the use of an equivalent of HIO4 and H2SO4 in
the cosolvent of MeCN/H2O (v:v = 1:1) as a reaction
condition could aﬀord the best result,7g where the PMP
protection group of (S)-4-methoxy-N-(2,2,2-triﬂuoro-1-
phenylethyl)aniline could be removed readily to give (S)-
2,2,2-triﬂuoro-1-phenylethanamine with the slightly decreased
enantioselectivity in 72% isolated yield, as shown in Scheme 2.
</para>
Scheme 2. Removal of the PMP Protection Group

entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

R1, R2

PMP, Ph
PMP, 4-FC6H4
PMP, 4-ClC6H4
PMP, 4-BrC6H4
PMP, 3-BrC6H4
PMP, 4-CF3C6H4
PMP, 4-MeC6H4
PMP, 4-MeOC6H4
PMP, 2-MeOC6H4
PMP, 2-thienyl
4-MeC6H4, Ph
4-MeC6H4, 4-FC6H4
4-MeC6H4, 4-BrC6H4
Ph, Ph
4-ClPh, Ph
1-naphthyl, Ph
2-naphthyl, Ph

2
2a
2b
2c
2d
2e
2f
2g
2h
2i
2j
2k
2l
2m
2n
2o
2p
2q

time (h)

yield (%)

ee (%)b

8
8
8
8
8
5
17
9
8
20
8
8
8
8
8
12
9

93
91
90
88
94
93
75
87
82
70
88
93
89
94
91
89
90

97
97
99
95
95
97
96
98
93
97
95
94
95
96
95
96
99

aReactions were performed with 4.0 μmol of catalyst D, 0.20 mmol of
α-triﬂuoromethylimines, 1.0 mmol of HCOONa in 2.0 mL of water/
DMF (v/v = 1/1) at 40 °C. bDetermined by HPLC.
<para sub="scope">
in general, high yields, no intermediate products, and excellent
enantioselectivities were obtained under the optimal reaction
conditions for all tested substrates. It is noteworthy that the
structures and electronic properties of substituents in the
aromatic ring at the R2 group did not aﬀect signiﬁcantly their
enantioselectivities; that is, various electron-withdrawing and
electron-donating substituents in the Ar moiety at the R2 group
were equally eﬃcient (entries 2−9). However, the slight eﬀects
on yields could be observed,
in which electron-withdrawing
substituents in the Ar moiety at the R2 group had slightly higher
yields than those of electron-donating substituents (entries 2−6
versus entries 7−9).
the thienyl-substituted
substrate could be also converted to the corresponding chiral
products with excellent enantioselectivity (Table 2, entry 10).
Moreover, besides
the general p-methoxyphenyl (PMP)
protection group, other protection groups, such as p-tolyl, Ph,
and naphthyl, could also be expanded to the asymmetric
transfer hydrogenation, providing the desirable chiral aryltri-
ﬂuoromethylamines with high enantioselectivities (entries 11−
17).
</para>
In addition,

In conclusion, by the further

investigation of Noyori’s
catalysts, we ﬁnd that RuCl[(S,S)-TsDPEN)](mesitylene) is an
eﬃcient catalyst in the asymmetric transfer hydrogenation of
acyclic α-triﬂuoromethylimines with sodium formate as a
hydrogen resource and water−dimethylformamide as a
cosolvent, which produces various chiral aryl-substituted α-
triﬂuoromethylamines in high yields and enantioselectivities
(93−99% ee). Furthermore, the mild reaction conditions make
this asymmetric reaction an attractive character
the
construction of valuable α-triﬂuoromethylamines through the
transformations of strong electron-withdrawing α-triﬂuorome-
thylimines.
■ EXPERIMENTAL SECTION

for
<para sub=“exp”>
General Methods. All manipulations were carried out under an
inert atmosphere using a nitrogen-ﬁlled glovebox or Schlenk
techniques. Deuterated solvents were purchased commercially and
were degassed and stored over activated 4 Å molecular sieves. The α-
triﬂuoromethylimines and (S)-2,2,2-triﬂuoro-1-phenylethanamine
were prepared according to the published procedures.7d−g,11 All
other reagents were obtained from commercial sources and used
without further puriﬁcation. The 1H, 19F, and 13C{1H}NMR spectra
were recorded at 400, 376, and 101 MHz, respectively. 19F NMR
chemical shifts were determined relative to CFCl3 as the outside
standard and low ﬁeld is positive. Mass spectrometry was performed
on a GC/MS spectrometer with the electron impact (EI) ionization
technique. HRMS data were recorded on a GC-TOF instrument using
the EI technique. The enantiomeric excesses (ee) were determined by
an HPLC analysis with a UV−vis detector using a Daicel OD-H or
OB-H or AD-H Chiralcel column (Φ 0.46 × 25 cm).
Typical Procedure for Asymmetric Transfer Hydrogenation
of α-Triﬂuoromethylimines. The catalyst (2.49 mg, 4.0 μmol, 2.0
mol %), α-triﬂuoromethylimines (0.20 mmol), HCOONa (68.0 mg,
1.0 mmol, 5.0 equiv) and 2.0 mL of H2O/DMF (v/v = 1/1) were
added sequentially to a 5.0 mL round−bottom ﬂask. The mixture was
then stirred at 40 °C for 5−12 h. During this period, the reaction was
monitored constantly by TLC. After completion of the reaction, the
aqueous solution was extracted with ethyl ether (3 × 3.0 mL). The
combined ethyl ether extracts were washed with NaHCO3 and brine,
and then dehydrated with Na2SO4. After evaporation of ethyl ether,
</para>
3710

DOI: 10.1021/acs.joc.5b00177
J. Org. Chem. 2015, 80, 3708−3713

The Journal of Organic Chemistry

Note
<para sub=“exp”>
the residue was puriﬁed by silica gel ﬂash column chromatography to
aﬀord the desired product. The yields were determined by 1H NMR,
and the ee values were determined by a HPLC analysis using a UV−vis
detector and a Daicel chiralcel column (Φ 0.46 × 25 cm).7d−g,10
2a:.7d,e 52.266 mg, 0.186 mmol, 93% yield, 97% ee; 1H NMR (400
MHz, CDCl3): δ 7.49−7.47 (m, 2H), 7.44−7.39 (m, 3H), 6.79−6.75
(m, 2H), 6.66−6.62 (m, 2H), 4.87−4.81(m, 1H), 3.74 (s, 3H);
13C{1H} NMR (101 MHz, CDCl3): δ 153.7, 139.9, 134.7, 129.4,
129.2, 128.3, 125.6 (q, JC−F = 280 Hz), 118.3, 116.1, 115.2, 60.7 (q,
JC−F = 30 Hz), 55.8; GC/MS (m/z): 281; HPLC (OD-H, elute:
Hexanes/i-PrOH = 95/5, detector: 254 nm, ﬂow rate: 0.5 mL/min, 25
°C), t1 = 16.5 min (major), t2 = 18.9 min.
2b:7f 54.418 mg, 0.182 mmol, 91% yield, 97% ee; 1H NMR (400
MHz, CDCl3): δ 7.47−7.43 (m, 2H), 7.12−7.07 (m, 2H), 6.77−6.74
(m, 2H), 6.60−6.59 (m, 2H), 4.85−4.79(m, 1H), 4.07 (s, 1H), 3.74 (s,
3H); 13C{1H} NMR (101 MHz, CDCl3): δ 164.6, 162.1, 153.7, 139.5,
130.3, 130.0, 130.0, 125.3 (q, JC−F = 279 Hz), 116.0, 115.1, 61.3 (q,
JC−F = 29 Hz), 55.8; GC/MS (m/z): 299; HPLC (OD-H, elute:
Hexanes/i-PrOH = 95/5, detector: 254 nm, ﬂow rate: 0.5 mL/min, 25
°C), t1 = 21.94 min (major), t2 = 26.1 min.
2c:.7e,g 56.700 mg, 0.180 mmol, 90% yield, 99% ee; 1H NMR (400
MHz, CDCl3): δ 7.39−7.33 (m, 4H), 6.75−6.71 (m, 2H), 6.58−6.54
(m, 2H), 4.76−4.86 (m, 1H), 4.09 (s, 1H), 3.72 (s, 3H); 13C{1H}
NMR (101 MHz, CDCl3): δ 153.7, 139.3, 135.3, 133.0, 129.6, 129.4,
125.1 (q, JC−F = 280 Hz), 116.1, 115.1, 61.3 (q, JC−F = 29 Hz), 55.9.
GC/MS (m/z): 315; HPLC (AD-H, elute: Hexanes/i-PrOH = 90/10,
detector: 254 nm, ﬂow rate: 0.8 mL/min, 25 °C), t1 = 12.0 min
(major), t2 = 14.9 min.

2d:.7e,g 63.184 mg, 0.176 mmol, 88% yield, 95% ee; 1H NMR (400
MHz, CDCl3): δ 7.52 (d, J = 8.8 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H),
6.78−6.73 (m, 2H), 6.01−6.56 (m, 2 H), 4.82−4.77 (m, 1H), 3.73 (s,
3H); 13C{1H} NMR (101 MHz, CDCl3): δ 153.7, 139.3, 133.5, 132.3,
129.9, 125.0 (q, JC−F = 281 Hz), 123.5, 116.0, 115.1, 61.5 (q, JC−F = 30
Hz), 55.9; GC/MS (m/z): 359; HPLC (OD-H, elute: Hexanes/i-
PrOH = 95/5, detector: 254 nm, ﬂow rate: 0.5 mL/min, 25 °C), t1 =
23.4 min (major), t2 = 30.2 min.
2e: 67.492 mg, 0.188 mmol, 94% yield, 95% ee; 1H NMR (400
MHz, CDCl3): δ 7.64 (s, 1H), 7.55−7.53 (m, 1H), 7.42 (d, J = 8.0 Hz,
1H), 7.31−7.27 (m, 1H), 6.80−6.76 (m, 2H), 6.63−6.59 (m, 2H),
4.85−4.79 (m 1H), 3.75 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3):
δ 153.8, 139.3, 136.9, 132.6, 131.3, 130.7, 126.9, 125.1 (q, JC−F = 281
Hz), 123.5, 116.0, 115.2, 61.5 (q, JC−F = 30 Hz), 55.9; 19F NMR (376
MHz, CDCl3): δ −72.80 (d, J = 7.5 Hz); GC/MS (m/z): 359; HR-MS
(ESI) [M + H]+ (m/z): calcd for C15H13BrF3NO, 360.0205, found
360.0196. HPLC (OD-H, elute: Hexanes/i-PrOH = 95/5, detector:
254 nm, ﬂow rate: 0.5 mL/min, 25 °C), t1 = 24.5 min (major), t2 =
29.9 min.

2f:.7d,e,g 64.914 mg, 0.186 mmol, 93% yield, 97% ee; 1H NMR (400
MHz, CDCl3): δ 7.67 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 8.4 Hz, 2H),
6.77−6.75 (m, 2H), 6.58 (d, J = 8.4 Hz, 2H), 4.94−4.88 (m, 1H), 3.74
(s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 153.9, 139.3, 138.6,
131.7, 131.5, 128.7, 126.1, 125.0 (q, JC−F = 280 Hz), 116.1, 115.2, 61.6
(q, JC−F = 30 Hz), 55.8; GC/MS (m/z): 349; HPLC (OB-H, elute:
Hexanes/i-PrOH = 90/10, detector: 254 nm, ﬂow rate: 0.5 mL/min,
25 °C), t1 = 26.7 min, t2 = 33.3 min (major).

2g:.7d,e 44.250 mg, 0.150 mmol, 75% yield, 93% ee; 1H NMR (400
MHz, CDCl3): δ 7.24 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H),
6.66−6.63 (m, 3H), 6.54−6.50 (m, 2H), 4.72−7.66 (m, 1H), 3.62 (s,
3H), 3.39 (s, 1H), 2.26 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
153.5, 139.8, 139.2, 131.5, 129.8, 128.0, 125.4 (q, JC−F = 280 Hz),
116.0, 115.1, 61.7 (q, JC−F = 29 Hz), 55.9, 21.4; GC/MS (m/z): 295;
HPLC (AD-H, elute: Hexanes/i-PrOH = 90/10, detector: 254 nm,
ﬂow rate: 0.8 mL/min, 25 °C), t1 = 10.1 min (major), t2 = 14.2 min.
2h:.7d,e 54.114 mg, 0.174 mmol, 87% yield, 98% ee; 1H NMR (400
MHz, CDCl3): δ 7.39 (d, J = 8.4 Hz, 2H), 6.96−6.93 (m, 2H), 6.78−
6.75 (m, 2H), 6.65−6.62 (m, 2H), 4.82−4.77 (m, 1H), 4.01 (bar, 1H),
3.83 (s, 3H), 3.74 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
160.3, 153.5, 139.9, 129.3, 126.5, 125.5 (q, JC−F = 280 Hz), 116.0,
115.1, 114.5, 61.4 (q, JC−F = 30 Hz), 55.9, 55.5; GC/MS (m/z): 311;

HPLC (AD-H, elute: Hexanes/i-PrOH = 90/10, detector: 254 nm,
ﬂow rate: 0.8 mL/min, 25 °C), t1 = 15.4 min (major), t2 = 22.8 min.
2i: 51.004 mg, 0.164 mmol, 82% yield, 93% ee; 1H NMR (400 MHz,
CDCl3): δ 7.37 (d, J = 7.6 Hz, 1H), 7.33−7.29 (m, 1H), 6.98−6.92
(m, 2H), 6.76−6.71 (m, 2H), 6.64−6.60 (m, 2H), 5.45−5.39 (m, 1H),
4.23 (bar, 1H), 3.88 (s, 3H), 3.70 (s, 3H); 13C{1H} NMR (101 MHz,
CDCl3): δ 158.0, 153.5, 134.0, 130.4, 128.4, 126.0 (q, JC−F = 281 Hz),
123.1, 121.3, 116.0, 115.8, 115.2, 111.5, 56.0, 55.8, 55.0(q, JC−F = 30
Hz); GC/MS (m/z): 311; 19F NMR (376 MHz, CDCl3): δ −72.74 (d,
J = 7.4 Hz); HR-MS (ESI) [M + H]+ (m/z): calcd for C16H16F3NO2,
312.1206, found 312.1209. HPLC (AD-H, elute: Hexanes/i-PrOH =
90/10, detector: 254 nm, ﬂow rate: 0.8 mL/min, 25 °C), t1 = 5.6 min
(major), t2 = 11.2 min.
2j:7e 40.180 mg, 0.140 mmol, 70% yield, 97% ee; 1H NMR (400
MHz, CDCl3): δ 7.34 (dd, J = 1.2 Hz, 1.2 Hz, 2H), 7.19 (d, J = 3.2 Hz,
2H), 7.05 (dd, J = 3.6, 3.6 Hz, 1H), 6.83−6.79 (m, 1H), 6.72−6.68
(m, 1H), 5.16−5.11 (m, 1H), 3.94 (bar, 1H), 3.76 (s, 3H); 13C{1H}
NMR (101 MHz, CDCl3): δ 154.0, 139.5, 137.6, 127.5, 127.3, 126.5,
125.0 (q, JC−F = 280 Hz), 116.4, 115.2, 58.3 (q, JC−F = 29 Hz), 55.8;
GC/MS (m/z): 287; HPLC (AD-H, elute: Hexanes/i-PrOH = 97/3,
detector: 254 nm, ﬂow rate: 1.0 mL/min, 25 °C), t1 = 12.0 min
(major), t2 = 14.6 min.
2k:7d 46.640 mg, 0.176 mmol, 88% yield, 95% ee; 1H NMR (400
MHz, CDCl3): δ 7.48 (d, J = 6.0 Hz, 2H), 7.44−7.38 (m, 3H), 6.99 (d,
J = 8.4 Hz, 2H), 6.58 (d, J = 8.4 Hz, 2H), 4.93−4.86 (m, 1H), 4.23 (d,
J = 7.2 Hz, 1H), 2.24 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
143.5, 134.6, 130.1, 129.3, 129.2, 128.9, 128.2, 125.5(q, JC−F = 280
Hz), 114.5, 61.2 (q, JC−F = 30 Hz), 20.6; 19F NMR (376 MHz,
CDCl3): δ −72.90 (d, J = 7.0 Hz); GC/MS (m/z): 265; HPLC (OD-
H, elute: Hexanes/i-PrOH = 97/3, detector: 254 nm, ﬂow rate: 1.0
mL/min, 25 °C), t1 = 8.5 min (major), t2 = 9.5 min.
2l: 52.638 mg, 0.186 mmol, 93% yield, 94% ee; 1H NMR (400 MHz,
CDCl3): δ 7.46 (dd, J = 6.4, 5.2 Hz, 2H), 7.13−7.07 (m, 2H), 7.00 (d,
J = 8.4 Hz, 2H), 6.56 (d, J = 8.4 Hz, 2H), 4.93−4.86 (m, 1H), 4.22 (d,
J = 6.8 Hz, 1H), 2.25 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
164.3, 162.06, 143.15, 130.1, 130.0, 129.0, 125.2(q, JC−F = 280 Hz),
116.2, 116.0, 114.4, 60.5 (q, JC−F = 29 Hz), 20.6; GC/MS (m/z): 283;
HR-MS (ESI) [M + H]+ (m/z): calcd for C15H13F4N, 284.1057, found
284.1055. HPLC (OD-H, elute: Hexanes/i-PrOH = 97/3, detector:
254 nm, ﬂow rate: 1.0 mL/min, 25 °C, t1 = 12.9 min (major), t2 = 17.6
min.
2m: 61.232 mg, 0.178 mmol, 89% yield, 95% ee; 1H NMR (400
MHz, CDCl3): δ 7.56−7.53 (m, 2H), 7.36 (d, J = 8.4 Hz, 2H), 6.99 (d,
J = 8.0 Hz, 2H), 6.54 (d, J = 7.6 Hz, 2H), 4.90−4.83 (m, 1H), 4.22 (d,
J = 6.0 Hz, 1H), 2.24 (s, 3H).; 13C{1H} NMR (101 MHz, CDCl3): δ
143.0, 133.5, 132.3, 130.1, 129.8, 129.1, 128.2, 125.0(q, JC−F = 280
Hz), 114.4, 60.8 (q, JC−F = 30 Hz), 20.6; GC/MS (m/z): 343; HR-MS
(ESI) [M + H]+ (m/z): calcd for C15H13BrF3N, 344.0256, found
344.0254. HPLC (OD-H, elute: Hexanes/i-PrOH = 95/5, detector:
254 nm, ﬂow rate: 1.0 mL/min, 25 °C), t1 = 14.0 min (major), t2 =
19.8 min.
2n:7d 47.188 mg, 0.188 mmol, 94% yield, 96% ee; 1H NMR (400
MHz, CDCl3): δ 7.49−7.38 (m, 2H), 7.18 (t, J = 7.6 Hz, 2H), 6.80 (t,
J = 7.6 Hz, 1H), 6.67 (d, J = 8.0 Hz, 2H), 4.97−4.91 (m, 1H);
13C{1H} NMR (101 MHz, CDCl3): δ145.7, 134.3, 128.1, 129.6, 129.4,
129.1, 128.1, 125.3 (q, JC−F = 280 Hz), 119.5, 114.2, 60.8 (q, JC−F = 30
Hz); GC/MS (m/z): 251; HPLC (AD-H, elute: Hexanes/i-PrOH =
95/5, detector: 254 nm, ﬂow rate: 1.0 mL/min, 25 °C), t1 = 7.7 min
(major), t2 = 10.0 min.
2o:10 51.870 mg, 0.182 mmol, 91% yield, 95% ee; 1H NMR (400
MHz, CDCl3): δ 7.54−7.47 (m, 5H), 7.22−7.18 (m, 2H), 6.67−6.63
(m, 2H), 5.00−4.93 (m, 1H), 4.47 (d, J = 5.6 Hz, 1H); 13C{1H} NMR
(101 MHz, CDCl3): δ 144.4, 133.9, 129.6, 129.5, 129.3, 128.1,
125.3(q, JC−F = 280 Hz), 124.3, 116.2, 116.0, 114.4, 61.0 (q, JC−F = 30
Hz), 20.6; 19F NMR (376 MHz, CDCl3): δ −72.76 (d, J = 7.1 Hz);
GC/MS (m/z): 285; HPLC (OD-H, elute: Hexanes/i-PrOH = 95/5,
detector: 254 nm, ﬂow rate: 0.5 mL/min, 25 °C), t1 = 14.8 min
(major), t2 = 18.3 min.

2p:7g 53.578 mg, 0.178 mmol, 89% yield, 96% ee; 1H NMR (400
MHz, CDCl3): δ 8.01 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 7.6 Hz, 1H),
</para>
3711

DOI: 10.1021/acs.joc.5b00177
J. Org. Chem. 2015, 80, 3708−3713

The Journal of Organic Chemistry
<para sub=“exp”>
7.59−7.52 (m, 4H), 7.47−7.43 (m, 3H), 7.36 (d, J = 8.4 Hz, 1H),
7.29−7.25 (m, 1H), 6.56 (d, J = 7.2 Hz, 1H), 5.20−5.07 (m, 2H);
13C{1H} NMR (101 MHz, CDCl3): δ 140.7, 134.6, 134.0, 129.5,
129.2, 129.1, 128.2, 126.3, 125.7, 124.3, 125.4 (q, JC−F = 281 Hz),
120.0, 119.9, 107.4, 60.8 (q, JC−F = 29 Hz); GC/MS (m/z): 301;
HPLC (OD-H, elute: Hexanes/i-PrOH = 95/5, detector: 254 nm,
ﬂow rate: 0.5 mL/min, 25 °C), t1 = 21.3 min, t2 = 30.6 min(major).
2q:7g 54.180 mg, 0.180 mmol, 90% yield, 99% ee; 1H NMR (400
MHz, CDCl3): δ 7.71−7.68(m, 2H), 7.59−7.53(m, 3H), 7.43−7.36
(m, 4H), 7.28−7.24 (m, 1H), 6.99 (dd, J = 2.4, 2.4 Hz, 1H), 6.84 (d, J
= 1.2 Hz, 1H), 5.12−5.07 (m, 1H); 13C{1H} NMR (101 MHz,
CDCl3): δ 143.3, 134.9, 134.1, 129.5, 129.4, 129.2, 128.5, 128.1, 127.8,
126.7, 126.5, 125.3 (q, JC−F = 281 Hz), 123.2, 118.0, 107.1, 60.6 (q,
JC−F = 29 Hz); GC/MS (m/z): 301; HPLC (AD-H, elute: Hexanes/i-
PrOH = 95/5, detector: 254 nm, ﬂow rate: 0.5 mL/min, 25 °C), t1 =
19.0 min (major), t2 = 31.2 min.
(S)-2,2,2-Triﬂuoro-1-phenylethanamine:7g 25.20 mg, 0.144 mmol,
72% yield, 96% ee; 1H NMR (400 MHz, CDCl3) δ 7.40−7.33 (m,
5H), 4.31 (q, J = 7.6 Hz, 1H), 1.84 (s, 2H); 13C NMR (CDCl3): δ
135.6, 131.4, 129.1, 128.8, 125.8 (q, JC−F = 280 Hz), 58.1 (q, JC−F = 30
Hz); HPLC (OD-H, elute: Hexanes/i-PrOH = 95/5, detector: 254
nm, ﬂow rate: 0.5 mL/min, 25 °C), t1 = 20.5 min (major), t2 = 26.21
min.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
Characterizations and chiral HPLC analysis of the catalytic
enantioselective reactions. This material
is available free of
charge via the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Author
*Tel: + 86 21 64321819. E-mail: ghliu@shnu.edu.cn (G.L.).
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

to the China National Natural Science
We are grateful
Foundation (21402120),
the Shanghai Sciences and Tech-
nologies Development Fund (13ZR1458700 and 12
nm0500500), the Shanghai Municipal Education Commission
(14YZ074, 13CG48, Young Teacher Training Project), and the
Specialized Research Fund for the Doctoral Program of Higher
Education (20133127120006).

■ REFERENCES

(1) (a) Hashiguchi, S.; Fujii, A.; Takehara, J.; Ikariya, T.; Noyori, R. J.
Am. Chem. Soc. 1995, 117, 7562. (b) Uematsu, N.; Fujii, A.;
Hashiguchi, S.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1996, 118,
4916. (c) Gao, J. X.; Ikariya, T.; Noyori, R. Organometallics 1996, 5,
1087. (d) Fujii, A.; Hashiguchi, S.; Uematsu, N.; Ikariya, T.; Noyori, R.
J. Am. Chem. Soc. 1996, 118, 2521. (e) Hashiguchi, S.; Fujii, A.; Haack,
K. J.; Matsumura, K.; Ikariya, T.; Noyori, R. Angew. Chem., Int. Ed.
Engl. 1997, 36, 288. (f) Noyori, R.; Hashiguchi, S. Acc. Chem. Res.
1997, 30, 97.
(2) (a) Ikariy, T.; John, A. B. Acc. Chem. Res. 2007, 40, 1300. (b) Xie,
J. H.; Zhu, S. F.; Zhou, Q. L. Chem. Rev. 2011, 111, 1713. (c) Ikariya,
T.; Murata, K.; Noyori, R. Org. Biomol. Chem. 2006, 4, 393. (d) Wang,
C.; Villa-Marcos, B.; Xiao, J. L. Chem. Commun. 2011, 47, 9773.
(e) Nugent, T. C.; El-Shazly, M. Adv. Synth. Catal. 2010, 352, 753.
(f) Wu, X.; Xiao, J. L. Chem. Commun. 2007, 2449. (g) Yu, Z. K.; Jin,
W. W.; Jiang, Q. B. Angew. Chem., Int. Ed. 2012, 51, 6060. (h) Li, C.
Q.; Xiao, J. L. J. Am. Chem. Soc. 2008, 130, 13208. (i) Chen, F.; Ding,
Z. Y.; Qin, J.; Wang, T. L.; He, Y. M.; Fan, Q. H. Org. Lett. 2011, 13,
4348. (j) Ding, Z. Y.; Chen, F.; Qin, J.; He, Y. M.; Fan, Q. H. Angew.

Note

Chem., Int. Ed. 2012, 51, 5706. (k) Chen, F.; Wang, T. L.; He, Y. M.;
Ding, Z. Y.; Li, Z. W.; Fan, Q. H. Chem.Eur. J. 2011, 17, 1109.
(3) (a) Murata, K.; Ikariya, T.; Noyori, R. J. Org. Chem. 1999, 64,
2186. (b) Barron-Jaime, A.; Narvaez-Garayzar, O. F.; Gonzalez, J.;
Ibarra-Galvan, V.; Aguirre, G.; Parra-Hake, M.; Chavez, D.;
Somanathan, R. Chirality 2011, 23, 178. (c) Perryman, M. S.;
Harris, M. E.; Foster, J. L.; Joshi, A.; Clarkson, G. J.; Fox, D. J. Chem.
Commun. 2013, 49, 10022. (d) Zhang, H.; Lian, C.; Zhu, J.; Deng, J.
Green Chem. 2007, 9, 23. (e) Wang, C.; Li, C.; Wu, X.; Pettman, A.;
Xiao, J. Angew. Chem., Int. Ed. 2009, 48, 6524. (f) Han, J.; Kang, S.;
Lee, H. K. Chem. Commun. 2011, 47, 4004.
(4) (a) Wu, X.; Liu, J.; Li, X.; Zanotti-Gerosa, A.; Hancock, F.; Vinci,
D.; Ruan, J.; Xiao, J. Angew. Chem. 2006, 45, 6718. (b) Zhou, H.; Li,
Z.; Wang, Z.; Wang, T.; Xu, L.; He, Y.; Fan, Q. H.; Pan, J.; Gu, L.;
Chan, A. S. Angew. Chem., Int. Ed. 2008, 47, 8464. (c) Kwak, S. H.;
Lee, S. A.; Lee, K.-I. Tetrahedron: Asymmetry 2010, 21, 800. (d) Wang,
T.; Zhuo, L. G.; Li, Z.; Chen, F.; Ding, Z.; He, Y.; Fan, Q. H.; Xiang, J.;
Yu, Z. X.; Chan, A. S. J. Am. Chem. Soc. 2011, 133, 9878. (e) Mashima,
K.; Abe, T.; Tani, K. Chem. Lett. 1998, 1199. (f) Murata, K.; Ikariya,
T.; Noyori, R. J. Org. Chem. 1999, 64, 2186. (g) Wu, Z.; Perez, M.;
Scalone, M.; Ayad, T.; Ratovelomanana-Vidal, V. Angew. Chem., Int. Ed.
2013, 52, 4925.
(5) (a) Nie, J.; Guo, H. C.; Cahard, D.; Ma, J. A. Chem. Rev. 2011,
111, 455. (b) Lim, J.; Taoka, B.; Otte, R. D.; Spencer, K.; Marshall, C.
G.; Young, J. R. J. Med. Chem. 2011, 54, 7334. (c) O’Shea, P. D.; Chen,
C. Y.; Gauvreau, D.; Hughes, F.; Gosselin, G.; Nadeau, C.; Volante, R.
P. J. Org. Chem. 2009, 74, 1605. (d) Zhang, N.; Ayral-Kaloustian, S.;
Nguyen, T.; Afragola, J.; Hernandez, J.; Lucas, R.; Gibbons, J.; Beyer,
C. J. Med. Chem. 2007, 50, 319. (e) Imamoto, T.; Iwadate, N.; Yoshida,
K. Org. Lett. 2006, 8, 2289. (f) Goulioukina, N. S.; Bondarenko, G. N.;
Lyubimov, S. E.; Davankov, V. A.; Gavrilov, K. N.; Beletskaya, I. P.
Adv. Synth. Catal. 2008, 350, 482.
(6) (a) Gosselin, F.; O’Shea, P. D.; Roy, S.; Reamer, R. A.; Chen, C.-
Y.; Volante, R. P. Org. Lett. 2005, 7, 355. (b) Prakash, G. K. S.;
Mandal, M.; Olah, G. A. Angew. Chem., Int. Ed. 2001, 40, 589.
(c) Kawai, H.; Kusuda, A.; Nakamura, S.; Shiro, M.; Shibata, N. Angew.
Chem., Int. Ed. 2009, 48, 6324. (d) Li, Y.; Hu, J. Angew. Chem,. Int. Ed.
2005, 44, 5882. (e) Li, Y.; Hu, J. Angew. Chem., Int. Ed. 2007, 46, 2489.
(f) Prakash, G. K. S.; Mandal, M.; Olah, G. A. Org. Lett. 2001, 3, 2847.
(g) Truong, V. L.; Pfeiffer, J. Y. Tetrahedron Lett. 2009, 50, 1633.
(h) Truong, V. L.; Ménard, M. S.; Dion, I. Org. Lett. 2007, 9, 683.
(i) Gosselin, F.; Roy, A.; O’Shea, P. D.; Chen, C. Y.; Volante, R. P.
Org. Lett. 2004, 6, 641. (j) Fries, S.; Pytkowicz, J.; Brigaud, T.
Tetrahedron Lett. 2005, 46, 4761. (k) Fustero, S.; del Pozo, C.;
Catalán, S.; Alemán, J.; Parra, A.; Marcos, V.; Ruano, J. L. G. Org. Lett.
2009, 11, 641.
(7) (a) Giacalone, F.; Gruttadauria, M.; Agrigento, P.; Noto, R.
Chem. Soc. Rev. 2012, 41, 2406. (b) Abe, H.; Amii, H.; Uneyama, K.
Org. Lett. 2001, 3, 313. (c) Suzuki, A.; Mae, M.; Amii, H.; Uneyama, K.
J. Org. Chem. 2004, 69, 5132. (d) Chen, M. W.; Duan, Y.; Chen, Q. A.;
Wang, D. S.; Yu, C. B.; Zhou, Y. G. Org. Lett. 2010, 12, 5075.
(e) Henseler, A.; Kato, M.; Mori, K.; Akiyama, T. Angew. Chem., Int.
Ed. 2011, 50, 8180. (f) Genoni, A.; Benaglia, M.; Massolo, E.; Rossi, S.
Chem. Commun. 2013, 49, 8365. (g) Dai, X. Y.; Cahard, D. Adv. Synth.
Catal. 2014, 356, 1317. (h) Mikami, K.; Murase, T.; Zhai, L.;
Kawauchi, S.; Itoh, Y.; Ito, S. Tetrahedron Lett. 2010, 51, 1371.
(8) (a) Zhang, D. C.; Cheng, T. Y.; Zhao, Q. K.; Xu, J. Y.; Liu, G. H.
Org. Lett. 2014, 16, 5764. (b) Zhang, D. C.; Gao, X. S.; Cheng, T. Y.;
Liu, G. H. Sci. Rep. 2014, 4, 5091. (c) Gao, X. S.; Liu, R.; Zhang, D. C.;
Wu, M.; Cheng, T. Y.; Liu, G. H. Chem.Eur. J. 2014, 20, 1515.
(d) Liu, R.; Cheng, T.; Kong, L. Y.; Chen, C.; Liu, G. H.; Li, H. X. J.
Catal. 2013, 307, 55. (e) Zhang, H. S.; Jin, R. H.; Yao, H.; Tang, S.;
Zhuang, J. L.; Liu, G. H.; Li, H. X. Chem. Commun. 2012, 48, 7874.
(f) Gao, F.; Jin, R. H.; Zhang, D. C.; Liang, Q. X.; Ye, Q. Q.; Liu, G. H.
Green Chem. 2013, 15, 2208. (g) Xia, D. Q.; Cheng, T. Y.; Xiao, W.;
Liu, K. K.; Wang, Z. L.; Liu, G. H.; Li, H. L.; Wang, W. ChemCatChem
2013, 5, 1784.

3712

DOI: 10.1021/acs.joc.5b00177
J. Org. Chem. 2015, 80, 3708−3713

The Journal of Organic Chemistry

(9) (a) Wu, X.; Li, X.; Hems, W.; King, F.; Xiao, J. L. Org. Biomol.
Chem. 2004, 2, 1818. (b) Wang, L.; Zhou, Q.; Qu, C.; Wang, Q.; Cun,
L.; Zhu, J.; Deng, J. Tetrahedron 2013, 69, 6500.
(10) (a) Johnson, T.; Lautens, M. Org. Lett. 2013, 15, 4043.
(b) Allendörfer, N.; Sudau, A.; Bräse, S. Adv. Synth. Catal. 2010, 352,
2815. (c) Fu, P.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc.
2008, 130, 5530.
(11) (a) Enders, D.; Gottfried, K.; Raabe, G. Adv. Synth. Catal. 2010,
352, 3147. (b) Abid, M.; Savolainen, M.; Landge, S.; Hu, J. B.; Prakash,
G. K. S.; Olah, G. A.; Török, B. J. Fluorine Chem. 2007, 128, 587.
(c) Li, C. L.; Chen, M. W.; Zhang, X. G. J. Fluorine Chem. 2010, 131,
856.

Note

3713

DOI: 10.1021/acs.joc.5b00177
J. Org. Chem. 2015, 80, 3708−3713

